Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure

American Heart Journal

Volumn 164, Issue 6, 2012, Pages 862-868

  Shah, Ravi V ^a,e   McNulty, Steven ^b   O'Connor, Christopher M ^c   Felker, G Michael ^c   Braunwald, Eugene ^d,e   Givertz, Michael M ^d,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FUROSEMIDE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DEHYDRATION; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CREATININE; CYSTATIN C; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PAIN MEASUREMENT; PATIENT READMISSION; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84870291890     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.08.019     Document Type: Article

References (19)

1. H.A. Cooper, D.L. Dries, and C.E. Davis Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 1999 1311 1315
2. S. Eshaghian, T.B. Horwich, and G.C. Fonarow Relation of loop diuretic dose to mortality in advanced heart failure Am J Cardiol 97 2006 1759 1764
3. M. Gheorghiade, and P.S. Pang Acute heart failure syndromes J Am Coll Cardiol 53 2009 557 573
4. C. Ronco, M. Haapio, and A.A. House Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
5. D.C. Brater Diuretic therapy N Engl J Med 339 1998 387 395
6. W. Mullens, Z. Abrahams, and G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
7. J.G. Abdallah, R.W. Schrier, and C. Edelstein Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone J Am Soc Nephrol 12 2001 1335 1341
8. G.M. Felker, K.L. Lee, and D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
9. D.R. Salvador, N.R. Rey, and G.C. Ramos Continuous infusion versus bolus injection of loop diuretics in congestive heart failure Cochrane Database Syst Rev 2005 CD003178
10. M.R. Vasko, D.B. Cartwright, and J.P. Knochel Furosemide absorption altered in decompensated congestive heart failure Ann Intern Med 102 1985 314 318
11. J.M. Testani, T.P. Cappola, and C.M. Brensinger Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure J Am Coll Cardiol 58 2011 375 382
12. W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
13. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
14. M. Jessup Defining success in heart failure: the end-point mess Circulation 121 2010 1977 1980
15. R.H. Mehta, J.G. Rogers, and V. Hasselblad Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure Am J Cardiol 103 2009 76 81
16. M. Gheorghiade, M.A. Konstam, and J.C. Burnett Jr. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials JAMA 297 2007 1332 1343
17. M.A. Konstam, M. Gheorghiade, and J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
18. R.V. Shah, and M.M. Givertz Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome Curr Heart Fail Rep 6 2009 176 181
19. R.W. Schrier Blood urea nitrogen and serum creatinine: not married in heart failure Circ Heart Fail 1 2008 2 5